
How To Keep Cells Alive in Transit: Why Hypothermic Transport is the Smarter Alternative
Discover why hypothermic cell transport is safer and smarter than cryopreservation or room temp methods for preserving cell viability in transit.
Discover why hypothermic cell transport is safer and smarter than cryopreservation or room temp methods for preserving cell viability in transit.
The rapid growth of translational applications for mesenchymal stem cells (MSCs) has heightened the need for efficient, scalable production systems. Central to this effort is
Stem cells are revolutionizing biomedical research and healthcare, offering unprecedented potential for regenerative medicine and disease treatment. Whether you are a seasoned researcher or just
Welcome to the first episode “Stem Cell Culture Shock No More” of our lab Life, Simplified series featuring Dr Ruttachuk Rungsiwiwut (Aon)! In this episode,
Cell and gene therapies are at the forefront of modern medicine, offering the potential to cure a wide range of diseases. Expanding these therapies from
Producing human Mesenchymal Stem Cells (MSCs) on a clinical scale is a complex endeavor, as there are no standardized optimal culture conditions universally adopted across
Atlantis Bioscience is thrilled to announce the inaugural International Cellular Therapeutics Conference (ICT Conference), happening this May 29th 2024 in Thailand! Partnering with the esteemed
The Future is Flexible: Summary Substrate stiffness serves as a critical determinant of MSC behaviour, exerting profound effects on adhesion, proliferation, migration, and differentiation. Understanding
The use of mesenchymal stem cells (MSCs) in clinical trials has witnessed a global surge, positioning MSCs as one of the most sought-after regenerative cell
Discover how MSC spheroids boost therapy. Learn mechanisms, production techniques, and in vivo effects for enhanced treatment outcomes.
Humanised mice provide preclinical models to assess the immunomodulatory potential of Mesenchymal Stem Cells (MSCs) for regenerative medicine. Discover how these models help develop novel, safer cell therapies for various diseases.
Discover current clinical trials using Mesenchymal Stem Cells (MSCs) for cancer therapy. Learn how MSCs are being studied to treat cancer and alleviate side effects of traditional therapies.
Optimize stem cell cancer therapy research with Mesenchymal Stem Cells (MSCs) quality control. Ensure purity, viability, and functionality for reliable, reproducible results.
Summary The field of cancer therapy is undergoing transformative changes, driven by the following trends: iPSC-derived MSCs, MSCs-derived EVs, and Cas9-mediated gene editing in MSCs.
The STEMGOLD High-Performance MSC Growth Medium kit comes with a reliable and comprehensive protocol to ensure optimal results. The protocol begins with the preparation of the
STEMGOLD, our high-performance mesenchymal stem cell (MSC) growth medium, optimized for your most demanding cell culture needs.
MSCs are new hope to treat neurodegenerative illnesses such as stroke, traumatic brain injury, Alzheimer’s disease, Parkinson’s disease, and more. Find out how.
MSCs have been shown to promote and improve wound recovery in medical applications by directly reducing the inflammatory response & recruiting tissue repair mediators.
MSC treatment has demonstrated their ability to develop into chondrocytes, healing tissue by producing collagen and matrix, lower inflammation, and provide pain relief for osteoarthritis.
Extracellular vesicles (EVs) are nanoscale lipid bilayer vesicles that are secreted by almost all cell types into the extracellular environment. EVs have a wide
Mesenchymal stem cells (MSCs) are adult multipotent cells that have been shown to have extraordinary anticancer properties, making them a unique option for cancer treatment.
Cancer is a disease that can develop anywhere in our body as a result of excessive cell division. The location and cell types influence the etiology, symptoms, severity, and therapeutic approaches. In brain tumours, more than 75% of adults are affected by glioblastoma. The average survival rate is only two years after diagnosis, and the progression of therapeutic strategies is limited and challenging. These are mainly due to the blood-brain barrier (BBB) blockage, which makes intravenous chemotherapeutic compounds difficult to get through, and the relative rarity of this kind of cancer, which makes it difficult to attract pharmaceutical companies.
Stem cell therapy is one of the most promising approaches in the field of regenerative medicine. It is to promote the repair response of the diseased or injured tissue to restore the lost function. Many diseases can be targeted by cell therapy. These include blood-related diseases, neuronal degenerative diseases, ischemic and cardiovascular disorders, bone and cartilage diseases, wound healing, etc.Â
Date: 26th February 2021, Friday
Time: 10.00am – 11.00am
Contact our Customer Care, Sales & Scientific Assistance
Consult and asked questions about our products & services
Documentation of Technical & Safety Data Sheet, Guides and more...